The Medicine Maker’s Post

Have you ever wondered how drug prescription prices have become so costly, and why? Our very own Amar Lunagaria explains how the pharmacy benefits managers (PBM's) in the pharmaceutical world impacts the end user pricing that most of us see today, and how NiHowdy aims to leverage this position to lower prescription costs. #costfreeprescriptions #reshapingpharma #nihowdyrx

Finally, a company with a mission dedicated to helping everyday people, not just increasing shareholder value...

Explore the implications of the Biden Administration's negotiated Maximum Fair Prices (MFPs) in our crisp, informative article. Discover how these prices will affect the pharmaceutical industry, save the government significant sums, and set the stage for future drug pricing negotiations. https://pwc.to/3yXMLKD

Choosing the right container closure system (#CCS) format is crucial, so it's important to have a thorough understanding of the various components included in the CCS, their required function, storage temperature and conditions, and the overall administration of the drug product. West Pharmaceutical Services provides an overview: https://lnkd.in/eC_-wDYU

If you represent or support a pharmaceutical manufacturer, chances are good you’ve seen all the conversation around biosimilars heating up. In July alone, we saw an unprecedented number (seven!) of biosimilars for Humira launch simultaneously. Interestingly, though, if you look at the conversation going on in the marketplace, the bulk of the discussion about which will be adopted and why is focused on behind-the-scenes pricing. However, as many recent reports and our experience indicate, that’s not really what’s standing in the way of adoption.

The German health technology assessment of newly approved drugs aims to relate the declared added benefit with the pricing of pharmaceutical products. In our latest HTAQ article, our experts share how the outcome of the AMNOG benefit assessment affects reimbursement negotiations: https://ow.ly/NUES50S2j2q

Share your latest updates with ease! 📢 With The Guide of The Pharmaceutical Marketing Group, you can post important announcements directly on your listing. Keep your customers informed and engaged with real-time updates. Add your listing today: https://bit.ly/3pYKo1V #PharmaMarketing #BusinessSuccess #TheGuideTPMG #Announcements #BusinessGrowth"

Last month, we discussed developments in the US pharmaceutical distribution system. Now, we look at more current developments focusing on CVS Health, which is carving out a vertically integrated space at every level of pharmaceutical distribution. https://ow.ly/PV7850QphBh #intellusWW #WeAreIntellusWW #intellusYP #mrx #insights #HCinsights #IntellusMemberNews

Over 75% of patients have now accessed care virtually. As expectations for digital care continue to rise, #DirectToConsumer models should be top of mind for pharmaceutical manufacturers. Join our upcoming webinar on June 25 to hear from seasoned leaders on the current state of virtual care, and learn effective strategies to build a strong DTC model that exceeds patient expectations. Save your spot: https://lnkd.in/gNiRzZH4

Could it happen in #pharma? No more prior authorizations? Farewell to step-edits? Return of control of pricing to the patient/consumer? Sounds lovely, doesn’t it? Read William Roth's latest article to learn more about changes in drug distribution, pricing, access, and patient affordability.